Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Free Cash Flow Generation Index
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Free Cash Flow Generation Index of 0.97x as of September 2025. Free cash flow of CN¥385.83 Million represents 1% of operating cash flow (CN¥399.43 Million). See how liquid is Shenzhen Hepalink Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shenzhen Hepalink Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2025)
Historical FCF Generation Index trend for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. Explore Shenzhen Hepalink Pharmaceutical Co Ltd (002399) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Year-by-year Free Cash Flow Generation Index for Shenzhen Hepalink Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Shenzhen Hepalink Pharmaceutical Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | CN¥1.59 Billion | CN¥1.71 Billion | CN¥121.10 Million | ▲ +2.4% |
| 2024 | 0.91x | CN¥1.99 Billion | CN¥2.19 Billion | CN¥202.77 Million | ▲ +874.5% |
| 2023 | -0.12x | CN¥-46.66 Million | CN¥398.22 Million | CN¥444.88 Million | ▲ +97.5% |
| 2020 | -4.70x | CN¥-175.21 Million | CN¥37.28 Million | CN¥212.49 Million | ▼ -2462.3% |
| 2018 | 0.20x | CN¥132.86 Million | CN¥667.87 Million | CN¥535.01 Million | ▲ +611.3% |
| 2016 | -0.04x | CN¥-13.46 Million | CN¥346.07 Million | CN¥359.54 Million | ▼ -104.8% |
| 2015 | 0.81x | CN¥724.86 Million | CN¥893.71 Million | CN¥168.85 Million | ▼ -0.6% |
| 2014 | 0.82x | CN¥745.18 Million | CN¥912.80 Million | CN¥167.62 Million | ▲ +170.6% |
| 2013 | 0.30x | CN¥126.99 Million | CN¥420.97 Million | CN¥293.98 Million | ▼ -39.5% |
| 2012 | 0.50x | CN¥236.34 Million | CN¥473.89 Million | CN¥237.55 Million | ▼ -44.9% |
| 2011 | 0.90x | CN¥1.27 Billion | CN¥1.41 Billion | CN¥134.16 Million | ▲ +0.6% |
| 2010 | 0.90x | CN¥318.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▲ +6.3% |
| 2009 | 0.85x | CN¥300.89 Million | CN¥355.81 Million | CN¥54.91 Million | ▲ +15.8% |
| 2008 | 0.73x | CN¥29.32 Million | CN¥40.13 Million | CN¥10.81 Million | ▲ +433.6% |
| 2007 | 0.14x | CN¥1.90 Million | CN¥13.85 Million | CN¥11.95 Million | ▼ -83.9% |
| 2006 | 0.85x | CN¥60.95 Million | CN¥71.66 Million | CN¥10.71 Million | — |